Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr

Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr

By: IPP Bureau

Last updated : January 26, 2024 11:55 am



Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023


Astec LifeSciences Limited has reported consolidated financial results for the period ended December 31, 2023.

Astec LifeSciences has posted net loss of Rs. 24.33 crores for the period ended December 31, 2023 as against net loss of Rs. 13.42 crores for the period ended September 30, 2023. It posted net profit of Rs.0.83 crores for the period ended December 31, 2022.

Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023 as compared to Rs. 111.76 crores during the period ended September 30, 2023. It reported total income of Rs.120.96 crores during the period ended December 31, 2022.

For the 9 months period ended December 31, 2023, Astec LifeSciences has reported total income of Rs.308.02 crores as compared to Rs.511.67 crores during the 9 months period ended December 31, 2022.

The company has posted net loss of Rs.45.95 crores for the 9 months period ended December 31, 2023 as against net profit of Rs.30.54 crores for the 9 months period ended December 31, 2022.

Astec LifeSciences Limited

First Published : January 26, 2024 12:00 am